The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The New Guidance Subcommittee Gives ACR More Document Flexibility

The New Guidance Subcommittee Gives ACR More Document Flexibility

November 12, 2020 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
bsd / shutterstock.com; diplomedia / shutterstock.com

bsd / shutterstock.com; diplomedia / shutterstock.com

The ACR publishes multiple types of documents to provide guidance for its members, but some potentially beneficial topics have not fit neatly into existing production pathways. To answer the need, the ACR has formed a Guidance Subcommittee to the Quality of Care (QOC) Committee. This will allow the ACR to adapt more nimbly, when appropriate, to the informational needs of the rheumatology community.

You Might Also Like
  • ACR Releases COVID-19 Clinical Guidance for Pediatric Patients
  • ACR Advocates for Regulatory Relief and Flexibility for MACRA
  • The ACR Insurance Subcommittee Advocates for Fair Payer Policies
Explore This Issue
November 2020
Also By This Author
  • A Historical Look at the Characterization of Lupus as a Systemic Disease

Previously Existing Publication Pathways

The ACR publishes different kinds of helpful written materials, such as those geared to patient education. The ACR also provides a variety of guidance documents, some of which give clinical information to help inform care. Until now, most ACR-endorsed guidance documents have fallen into one of three categories: clinical practice guidelines, position statements and white papers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Clinical practice guidelines—with development overseen by the QOC Committee—are rigorously developed documents using codified processes, including systematic literature reviews, GRADE methodology, disclosure and conflict of interest evaluations and a formal peer review process. Guidelines typically require 18–24 months to complete.

The QOC Committee chair is Sindhu Johnson, MD, PhD, an associate professor in the Division of Rheumatology at the University of Toronto, Ontario, Canada. “Position papers are generally consensus driven, with some reference to published data. The intent of these papers is mainly advocacy, for example, to payers and government,” she explains. White papers frame issues and provide information about current data on a particular topic, but generally include few or no direct recommendations.

Johnson

Dr. Johnson

“Over the last few years, members of the rheumatology community have made a number of requests to evaluate or develop products that really don’t fit into any of those aforementioned types of documents,” Dr. Johnson says. For example, a document providing clinical information and recommendations may need to be produced more quickly than a traditional clinical practice guideline, or a topic may be too narrow for this purpose, requiring review of a smaller body of medical literature than a standard clinical practice guideline.

In February 2020, the ACR Board of Directors created the new Guidance Subcommittee, overseen by the QOC, to play a role in the development and potential endorsement of alternative types of documents that may provide helpful clinical recommendations. For ultimate ACR endorsement, a given document will need to be approved by the Guidance Subcommittee, then by the QOC and, ultimately, by the ACR Board of Directors.

The specifics of this involvement will vary by the situation. For example, the Guidance Subcommittee will provide feedback to outside groups that want to consult with the ACR to maximize the chance of creating a document that will ultimately achieve ACR endorsement. Other times, it may play no role in document creation but may decide whether to approve a submitted document and send it on for approval by the QOC.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The Guidance Subcommittee is also tasked with identifying topics that may be suited to these alternative types of guidance documents. In all cases, the Guidance Subcommittee will decide whether a document can be sent on to the QOC for potential ACR endorsement.

Pages: 1 2 3 | Single Page

Filed Under: From the College, Guidelines Tagged With: Committee on Quality of Care, Guidance SubcommitteeIssue: November 2020

You Might Also Like:
  • ACR Releases COVID-19 Clinical Guidance for Pediatric Patients
  • ACR Advocates for Regulatory Relief and Flexibility for MACRA
  • The ACR Insurance Subcommittee Advocates for Fair Payer Policies
  • Join the ACR COVID-19 Clinical Guidance Town Hall: May 6

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.